BioAge Labs, Inc.
BioAge Labs, Inc. (BIOA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BIOA · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
11
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
BioAge Labs, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
BIOA insider buying and selling by quarter
BIOA insider selling · BIOA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · BIOA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
BIOA executive sell shares · BIOA board member insider trading · BIOA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 23, 2026 | GOLDSTEIN DOV A MD CFO | Option | 3,542 | $16K | Form 4 |
| Apr 1, 2026 | RUBIN PAUL D Chief Medical Officer | Option | 3,383 | $22K | Form 4 |
| Apr 1, 2026 | RUBIN PAUL D Chief Medical Officer | Option | 5,437 | $22K | Form 4 |
| Apr 1, 2026 | RUBIN PAUL D Chief Medical Officer | Sale | 8,820 | $157K | Form 4 |
| Mar 2, 2026 | RUBIN PAUL D Chief Medical Officer | Option | 2,000 | $13K | Form 4 |
| Mar 2, 2026 | RUBIN PAUL D Chief Medical Officer | Option | 5,433 | $22K | Form 4 |
| Mar 2, 2026 | RUBIN PAUL D Chief Medical Officer | Sale | 7,433 | $151K | Form 4 |
| Mar 1, 2026 | GOLDSTEIN DOV A MD CFO | Option | 3,542 | $16K | Form 4 |
| Feb 2, 2026 | RUBIN PAUL D Chief Medical Officer | Option | 2,000 | $13K | Form 4 |
| Feb 2, 2026 | RUBIN PAUL D Chief Medical Officer | Option | 5,433 | $22K | Form 4 |
| Feb 2, 2026 | RUBIN PAUL D Chief Medical Officer | Sale | 7,433 | $139K | Form 4 |
| Feb 1, 2026 | GOLDSTEIN DOV A MD CFO | Option | 3,541 | $16K | Form 4 |
| Jan 16, 2026 | GOLDSTEIN DOV A MD CFO | Option | 3,542 | $16K | Form 4 |
| Jan 13, 2026 | GOLDSTEIN DOV A MD CFO | Option | 27,000 | $227K | Form 4 |
| Jan 13, 2026 | GOLDSTEIN DOV A MD CFO | Sale | 8,974 | $165K | Form 4 |
| Jan 13, 2026 | GOLDSTEIN DOV A MD CFO | Sale | 4,440 | $86K | Form 4 |
| Jan 13, 2026 | GOLDSTEIN DOV A MD CFO | Sale | 11,663 | $240K | Form 4 |
| Jan 13, 2026 | GOLDSTEIN DOV A MD CFO | Sale | 1,923 | $41K | Form 4 |
| Jan 13, 2026 | Fortney Kristen CEO · Director | Sale | 233,107 | $4.22M⚡ | Form 4 |
| Jan 2, 2026 | RUBIN PAUL D Chief Medical Officer | Option | 2,000 | $13K | Form 4 |
| Jan 2, 2026 | RUBIN PAUL D Chief Medical Officer | Option | 5,433 | $22K | Form 4 |
| Jan 2, 2026 | RUBIN PAUL D Chief Medical Officer | Sale | 7,433 | $95K | Form 4 |
| Dec 9, 2025 | RUBIN PAUL D Chief Medical Officer | Option | 18,000 | $118K | Form 4 |
| Dec 9, 2025 | RUBIN PAUL D Chief Medical Officer | Sale | 18,000 | $216K | Form 4 |
| Dec 4, 2025 | RUBIN PAUL D Chief Medical Officer | Option | 68,897 | $283K | Form 4 |
RUBIN PAUL D
Chief Medical Officer
Date
Apr 1
Shares
3,383
Price
$6.57
Value
$22K
RUBIN PAUL D
Chief Medical Officer
Date
Apr 1
Shares
5,437
Price
$4.11
Value
$22K
RUBIN PAUL D
Chief Medical Officer
Date
Apr 1
Shares
8,820
Price
$17.81
Value
$157K
RUBIN PAUL D
Chief Medical Officer
Date
Mar 2
Shares
2,000
Price
$6.57
Value
$13K
RUBIN PAUL D
Chief Medical Officer
Date
Mar 2
Shares
5,433
Price
$4.11
Value
$22K
RUBIN PAUL D
Chief Medical Officer
Date
Mar 2
Shares
7,433
Price
$20.30
Value
$151K
RUBIN PAUL D
Chief Medical Officer
Date
Feb 2
Shares
2,000
Price
$6.57
Value
$13K
RUBIN PAUL D
Chief Medical Officer
Date
Feb 2
Shares
5,433
Price
$4.11
Value
$22K
RUBIN PAUL D
Chief Medical Officer
Date
Feb 2
Shares
7,433
Price
$18.75
Value
$139K
Fortney Kristen
CEO · Director
Date
Jan 13
Shares
233,107
Price
$18.12
Value
$4.22M ⚡
RUBIN PAUL D
Chief Medical Officer
Date
Jan 2
Shares
2,000
Price
$6.57
Value
$13K
RUBIN PAUL D
Chief Medical Officer
Date
Jan 2
Shares
5,433
Price
$4.11
Value
$22K
RUBIN PAUL D
Chief Medical Officer
Date
Dec 9
Shares
18,000
Price
$6.57
Value
$118K
RUBIN PAUL D
Chief Medical Officer
Date
Dec 9
Shares
18,000
Price
$12.00
Value
$216K
RUBIN PAUL D
Chief Medical Officer
Date
Dec 4
Shares
68,897
Price
$4.11
Value
$283K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BIOA insider trading
BIOA insider trades
BioAge Labs, Inc. (BIOA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including RUBIN PAUL D (Chief Medical Officer), GOLDSTEIN DOV A MD (CFO), Fortney Kristen (CEO · Director). Over the past 12 months, 3 insiders have filed transactions with the SEC. BIOA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For BioAge Labs, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BIOA insider trading · 5 questionsThe insiders of BioAge Labs, Inc. (BIOA) include executives and directors such as RUBIN PAUL D (Chief Medical Officer), GOLDSTEIN DOV A MD (CFO), Fortney Kristen (CEO · Director), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026